nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—Abdominal pain lower—Telbivudine—hepatitis B	0.0528	0.0528	CcSEcCtD
Avanafil—Sinus headache—Telbivudine—hepatitis B	0.0515	0.0515	CcSEcCtD
Avanafil—Flank pain—Telbivudine—hepatitis B	0.0417	0.0417	CcSEcCtD
Avanafil—Rhinorrhoea—Telbivudine—hepatitis B	0.0207	0.0207	CcSEcCtD
Avanafil—Musculoskeletal pain—Telbivudine—hepatitis B	0.017	0.017	CcSEcCtD
Avanafil—Influenza like illness—Telbivudine—hepatitis B	0.0163	0.0163	CcSEcCtD
Avanafil—Blood creatinine increased—Entecavir—hepatitis B	0.0139	0.0139	CcSEcCtD
Avanafil—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0136	0.0136	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0128	0.0128	CcSEcCtD
Avanafil—Pain in extremity—Telbivudine—hepatitis B	0.0122	0.0122	CcSEcCtD
Avanafil—Upper respiratory tract infection—Entecavir—hepatitis B	0.0119	0.0119	CcSEcCtD
Avanafil—Rhinorrhoea—Lamivudine—hepatitis B	0.0117	0.0117	CcSEcCtD
Avanafil—Haematuria—Entecavir—hepatitis B	0.0109	0.0109	CcSEcCtD
Avanafil—Nasopharyngitis—Telbivudine—hepatitis B	0.0109	0.0109	CcSEcCtD
Avanafil—Gastritis—Telbivudine—hepatitis B	0.0108	0.0108	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0108	0.0108	CcSEcCtD
Avanafil—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0106	0.0106	CcSEcCtD
Avanafil—Influenza—Telbivudine—hepatitis B	0.0105	0.0105	CcSEcCtD
Avanafil—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0105	0.0105	CcSEcCtD
Avanafil—Oropharyngeal pain—Lamivudine—hepatitis B	0.0104	0.0104	CcSEcCtD
Avanafil—Oedema peripheral—Entecavir—hepatitis B	0.0101	0.0101	CcSEcCtD
Avanafil—Abdominal discomfort—Telbivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Avanafil—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00989	0.00989	CcSEcCtD
Avanafil—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00984	0.00984	CcSEcCtD
Avanafil—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00982	0.00982	CcSEcCtD
Avanafil—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00979	0.00979	CcSEcCtD
Avanafil—Musculoskeletal pain—Lamivudine—hepatitis B	0.00958	0.00958	CcSEcCtD
Avanafil—Immune system disorder—Entecavir—hepatitis B	0.00927	0.00927	CcSEcCtD
Avanafil—Wheezing—Lamivudine—hepatitis B	0.00919	0.00919	CcSEcCtD
Avanafil—Mental disorder—Entecavir—hepatitis B	0.00899	0.00899	CcSEcCtD
Avanafil—Malnutrition—Entecavir—hepatitis B	0.00894	0.00894	CcSEcCtD
Avanafil—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00872	0.00872	CcSEcCtD
Avanafil—Back pain—Adefovir Dipivoxil—hepatitis B	0.00843	0.00843	CcSEcCtD
Avanafil—Connective tissue disorder—Telbivudine—hepatitis B	0.00829	0.00829	CcSEcCtD
Avanafil—Cough—Adefovir Dipivoxil—hepatitis B	0.00761	0.00761	CcSEcCtD
Avanafil—Mediastinal disorder—Telbivudine—hepatitis B	0.0076	0.0076	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00755	0.00755	CcSEcCtD
Avanafil—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00742	0.00742	CcSEcCtD
Avanafil—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00742	0.00742	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00737	0.00737	CcSEcCtD
Avanafil—Malnutrition—Telbivudine—hepatitis B	0.00734	0.00734	CcSEcCtD
Avanafil—Infection—Entecavir—hepatitis B	0.00724	0.00724	CcSEcCtD
Avanafil—Nervous system disorder—Entecavir—hepatitis B	0.00715	0.00715	CcSEcCtD
Avanafil—Back pain—Telbivudine—hepatitis B	0.0071	0.0071	CcSEcCtD
Avanafil—Skin disorder—Entecavir—hepatitis B	0.00708	0.00708	CcSEcCtD
Avanafil—Muscle spasms—Telbivudine—hepatitis B	0.00706	0.00706	CcSEcCtD
Avanafil—Hypoglycaemia—Lamivudine—hepatitis B	0.00704	0.00704	CcSEcCtD
Avanafil—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00698	0.00698	CcSEcCtD
Avanafil—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00691	0.00691	CcSEcCtD
Avanafil—Insomnia—Entecavir—hepatitis B	0.0066	0.0066	CcSEcCtD
Avanafil—Somnolence—Entecavir—hepatitis B	0.00648	0.00648	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00648	0.00648	CcSEcCtD
Avanafil—Dyspepsia—Entecavir—hepatitis B	0.00642	0.00642	CcSEcCtD
Avanafil—Cough—Telbivudine—hepatitis B	0.00641	0.00641	CcSEcCtD
Avanafil—Gastrointestinal disorder—Entecavir—hepatitis B	0.0063	0.0063	CcSEcCtD
Avanafil—Fatigue—Entecavir—hepatitis B	0.00629	0.00629	CcSEcCtD
Avanafil—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00626	0.00626	CcSEcCtD
Avanafil—Chest pain—Telbivudine—hepatitis B	0.00625	0.00625	CcSEcCtD
Avanafil—Myalgia—Telbivudine—hepatitis B	0.00625	0.00625	CcSEcCtD
Avanafil—Arthralgia—Telbivudine—hepatitis B	0.00625	0.00625	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00621	0.00621	CcSEcCtD
Avanafil—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00614	0.00614	CcSEcCtD
Avanafil—Nasopharyngitis—Lamivudine—hepatitis B	0.00614	0.00614	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00606	0.00606	CcSEcCtD
Avanafil—Influenza—Lamivudine—hepatitis B	0.00594	0.00594	CcSEcCtD
Avanafil—Nervous system disorder—Telbivudine—hepatitis B	0.00588	0.00588	CcSEcCtD
Avanafil—Skin disorder—Telbivudine—hepatitis B	0.00582	0.00582	CcSEcCtD
Avanafil—Body temperature increased—Entecavir—hepatitis B	0.00576	0.00576	CcSEcCtD
Avanafil—Bronchitis—Lamivudine—hepatitis B	0.00571	0.00571	CcSEcCtD
Avanafil—Abdominal discomfort—Lamivudine—hepatitis B	0.00569	0.00569	CcSEcCtD
Avanafil—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00562	0.00562	CcSEcCtD
Avanafil—Pollakiuria—Lamivudine—hepatitis B	0.00548	0.00548	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00546	0.00546	CcSEcCtD
Avanafil—Insomnia—Telbivudine—hepatitis B	0.00542	0.00542	CcSEcCtD
Avanafil—Dyspepsia—Telbivudine—hepatitis B	0.00527	0.00527	CcSEcCtD
Avanafil—Asthenia—Entecavir—hepatitis B	0.00523	0.00523	CcSEcCtD
Avanafil—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00517	0.00517	CcSEcCtD
Avanafil—Fatigue—Telbivudine—hepatitis B	0.00516	0.00516	CcSEcCtD
Avanafil—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00511	0.00511	CcSEcCtD
Avanafil—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00503	0.00503	CcSEcCtD
Avanafil—Epistaxis—Lamivudine—hepatitis B	0.00499	0.00499	CcSEcCtD
Avanafil—Diarrhoea—Entecavir—hepatitis B	0.00499	0.00499	CcSEcCtD
Avanafil—Sinusitis—Lamivudine—hepatitis B	0.00497	0.00497	CcSEcCtD
Avanafil—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00487	0.00487	CcSEcCtD
Avanafil—Dizziness—Entecavir—hepatitis B	0.00482	0.00482	CcSEcCtD
Avanafil—Body temperature increased—Telbivudine—hepatitis B	0.00474	0.00474	CcSEcCtD
Avanafil—Connective tissue disorder—Lamivudine—hepatitis B	0.00467	0.00467	CcSEcCtD
Avanafil—Vomiting—Entecavir—hepatitis B	0.00464	0.00464	CcSEcCtD
Avanafil—Rash—Entecavir—hepatitis B	0.0046	0.0046	CcSEcCtD
Avanafil—Dermatitis—Entecavir—hepatitis B	0.00459	0.00459	CcSEcCtD
Avanafil—Headache—Entecavir—hepatitis B	0.00457	0.00457	CcSEcCtD
Avanafil—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00452	0.00452	CcSEcCtD
Avanafil—Rash—Adefovir Dipivoxil—hepatitis B	0.00449	0.00449	CcSEcCtD
Avanafil—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00448	0.00448	CcSEcCtD
Avanafil—Headache—Adefovir Dipivoxil—hepatitis B	0.00446	0.00446	CcSEcCtD
Avanafil—Nausea—Entecavir—hepatitis B	0.00433	0.00433	CcSEcCtD
Avanafil—Asthenia—Telbivudine—hepatitis B	0.0043	0.0043	CcSEcCtD
Avanafil—Immune system disorder—Lamivudine—hepatitis B	0.00429	0.00429	CcSEcCtD
Avanafil—Mediastinal disorder—Lamivudine—hepatitis B	0.00428	0.00428	CcSEcCtD
Avanafil—Pruritus—Telbivudine—hepatitis B	0.00424	0.00424	CcSEcCtD
Avanafil—Nausea—Adefovir Dipivoxil—hepatitis B	0.00423	0.00423	CcSEcCtD
Avanafil—Malnutrition—Lamivudine—hepatitis B	0.00414	0.00414	CcSEcCtD
Avanafil—Diarrhoea—Telbivudine—hepatitis B	0.0041	0.0041	CcSEcCtD
Avanafil—Back pain—Lamivudine—hepatitis B	0.004	0.004	CcSEcCtD
Avanafil—Muscle spasms—Lamivudine—hepatitis B	0.00398	0.00398	CcSEcCtD
Avanafil—Dizziness—Telbivudine—hepatitis B	0.00396	0.00396	CcSEcCtD
Avanafil—Vomiting—Telbivudine—hepatitis B	0.00381	0.00381	CcSEcCtD
Avanafil—Rash—Telbivudine—hepatitis B	0.00378	0.00378	CcSEcCtD
Avanafil—Dermatitis—Telbivudine—hepatitis B	0.00377	0.00377	CcSEcCtD
Avanafil—Headache—Telbivudine—hepatitis B	0.00375	0.00375	CcSEcCtD
Avanafil—Vertigo—Lamivudine—hepatitis B	0.00372	0.00372	CcSEcCtD
Avanafil—Cough—Lamivudine—hepatitis B	0.00361	0.00361	CcSEcCtD
Avanafil—Nausea—Telbivudine—hepatitis B	0.00356	0.00356	CcSEcCtD
Avanafil—Arthralgia—Lamivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Avanafil—Chest pain—Lamivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Avanafil—Myalgia—Lamivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.0035	0.0035	CcSEcCtD
Avanafil—Dry mouth—Lamivudine—hepatitis B	0.00344	0.00344	CcSEcCtD
Avanafil—Infection—Lamivudine—hepatitis B	0.00335	0.00335	CcSEcCtD
Avanafil—Nervous system disorder—Lamivudine—hepatitis B	0.00331	0.00331	CcSEcCtD
Avanafil—Skin disorder—Lamivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Avanafil—Hypotension—Lamivudine—hepatitis B	0.00315	0.00315	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00308	0.00308	CcSEcCtD
Avanafil—Insomnia—Lamivudine—hepatitis B	0.00305	0.00305	CcSEcCtD
Avanafil—Somnolence—Lamivudine—hepatitis B	0.003	0.003	CcSEcCtD
Avanafil—Dyspepsia—Lamivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Avanafil—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00291	0.00291	CcSEcCtD
Avanafil—Fatigue—Lamivudine—hepatitis B	0.00291	0.00291	CcSEcCtD
Avanafil—Constipation—Lamivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Avanafil—Body temperature increased—Lamivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Avanafil—Asthenia—Lamivudine—hepatitis B	0.00242	0.00242	CcSEcCtD
Avanafil—Pruritus—Lamivudine—hepatitis B	0.00239	0.00239	CcSEcCtD
Avanafil—Diarrhoea—Lamivudine—hepatitis B	0.00231	0.00231	CcSEcCtD
Avanafil—Dizziness—Lamivudine—hepatitis B	0.00223	0.00223	CcSEcCtD
Avanafil—Vomiting—Lamivudine—hepatitis B	0.00215	0.00215	CcSEcCtD
Avanafil—Rash—Lamivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Avanafil—Dermatitis—Lamivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Avanafil—Headache—Lamivudine—hepatitis B	0.00212	0.00212	CcSEcCtD
Avanafil—Nausea—Lamivudine—hepatitis B	0.00201	0.00201	CcSEcCtD
